Researchers at Stanford have developed a new water-based disinfectant with the potential to destroy a wide variety of pathogens and significantly improve healthcare settings.
Stanford researchers have developed a damage free method for activating buried p-type or Mg-doped epitaxial layers in III-nitride devices that improves performance and can reduce device cost when used as edge termination.
Researchers from Stanford and UC Santa Barbara have created a novel robot that blends traditional and soft robotics. This human-scale pneumatic robot can change shape and move independently once inflated, without needing a constant power or air source.
Researchers at Stanford have developed prodrug derivatives of protein kinase C (PKC) modulators that have lower toxicity and are more effective than the parent compound. PKC modulators are being developed to treat a variety of diseases.
Researchers at Stanford have developed a method of preventing Graft versus Host Disease (GVHD) by inhibiting a specific immune receptor. GVHD is a major debilitating complication of transplantation.
Stanford researchers at the Xing Lab have developed a novel technique to enable retrospective tuning of soft tissue contrast in MRI (i.e. adjusting the contrast after the image acquisition) using a deep learning-based strategy.
Researchers at Stanford have developed humanized therapeutic antibodies to treat cancers, particularly melanoma, inflammatory disorders such as sarcoidosis and skin and organ fibrosis.
An interdisciplinary team of Stanford engineers have developed a low-cost, patented, in situ method to efficiently produce electricity from organic matter such as wastewater.
Stanford researchers have developed a new method and medical device to close the abdominal wall fascia after laparotomy to reduce the incidence of incisional hernias. Incisional hernias occur in nearly 50% of high risk patients leading to costs of about $3B annually.
Stanford researchers have discovered that dietary metabolites, specifically alpha-ketoglutarate, are able to delay retinal degeneration to treat blinding retinal diseases regardless of the type of retinal condition.